Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V-01 Booster Phase III Trial
NCT05096832Phase 3Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Nov 2021
- Primary completion
- Feb 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of V-01 in coronavirus disease 2019 (COVID-19), sponsored by Livzon Pharmaceutical Group Inc.. Started Nov 2021; status: completed.
02
Drugs
V-01
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05096832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096832.